Ivanna Shymanska
Research Subjects
Ivanna Shymanska has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Halyna Makukh
Ivan Franko National University of Lviv 4 Hrushevsky St. 79005 Lviv Ukraine
4 shared publications H. Makuh
ТОВ «Науковий медико-генетичний центр «Леоген»», Україна, 79059, м. Львів, вул. Максимовича, 7г; Національний університет ім. Івана Франка, Україна, 79000, м. Львів, вул. Грушевського, 4; Регіональний центр неонатального скринінгу, КНП «Львівський обласний клінічний перинатальний центр», Україна, 79032, м. Львів, вул. Д. Вашингтона, 9
1 shared publicationIgor Belozorov
Department of Surgical Diseases, Operative Surgery and Topographical Anatomy, School of Medicine, V.N. Karazin Kharkiv National University, Kharkiv, Ukraine
1 shared publication- Iurii Sadovnychenko
Kharkiv National Medical University
1 shared publication - L. B. Chorna
ДУ «Інститут спадкової патології НАМН України», Україна, 79008, м. Львів, вул. Лисенка, 31а
1 shared publication Larysa Roshcheniuk
Department of Dermatology, Venereology and AIDS, 2nd Medical Faculty, Kharkiv National Medical University, Kharkiv, Ukraine; Regional Clinical Dispensary for Skin and Venereal Diseases no. 1, Kharkiv, Ukraine
1 shared publication
Latest Publications
- Open Access
- 1 September 2025
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Faktori eksperimental'noi evolucii organizmiv
- Vol. 37, 64-70
Application of molecular-genetic approaches in Cftr gene variant diagnostics: historical perspective and personal experience
Aim. To analyze the evolution of molecular-genetic methods for cystic fibrosis diagnosis, assess their effectiveness, advantages, and limitations, and determine optimal approaches for detecting CFTR gene variants. Methods. An analysis of the national registry of cystic fibrosis patients was conducted, along with laboratory studies performed at the Institute of Hereditary Pathology and the Scientific Medical-Genetic Center “LeoGene”. The study investigated methods including heteroduplex analysis, restriction analysis, MLPA, INNO-LiPA CFTR, TaqMan, Sanger sequencing, and NGS. Results. It was shown that the combined use of first-line methods identifying major population variants, along with MLPA, allows the detection of up to 70 % of CFTR variants. NGS provides a more detailed mutation analysis, including rare variants. Conclusions. The most effective approach is a stepwise strategy, incorporating initial screening for common variants followed by NGS analysis in case of a negative result. The use of international HGVS standards and databases such as CFTR2 and NCBI is crucial for the unification of diagnostic conclusions.
- 1 September 2025
- Published by Institute of Molecular Biology and Genetics (NAS Ukraine) in Faktori eksperimental'noi evolucii organizmiv
- Vol. 37, 64-70
Open AccessApplication of molecular-genetic approaches in Cftr gene variant diagnostics: historical perspective and personal experience
Aim. To analyze the evolution of molecular-genetic methods for cystic fibrosis diagnosis, assess their effectiveness, advantages, and limitations, and determine optimal approaches for detecting CFTR gene variants. Methods. An analysis of the national registry of cystic fibrosis patients was conducted, along with laboratory studies performed at the Institute of Hereditary Pathology and the Scientific Medical-Genetic Center “LeoGene”. The study investigated methods including heteroduplex analysis, restriction analysis, MLPA, INNO-LiPA CFTR, TaqMan, Sanger sequencing, and NGS. Results. It was shown that the combined use of first-line methods identifying major population variants, along with MLPA, allows the detection of up to 70 % of CFTR variants. NGS provides a more detailed mutation analysis, including rare variants. Conclusions. The most effective approach is a stepwise strategy, incorporating initial screening for common variants followed by NGS analysis in case of a negative result. The use of international HGVS standards and databases such as CFTR2 and NCBI is crucial for the unification of diagnostic conclusions.
- Open Access
- 1 March 2025
- Published by Ivan Franko National University of Lviv in Studia Biologica
- Vol. 19 (1) , 35-46
Comparative analysis of two TREC/KREC quantification methods for newborn screening of primary immunodeficiency with T- and B-lymphopenia used in Ukraine
Background. Primary immunodeficiency (PID) compromise the immune system, leaving newborns highly vulnerable to infections. Severe combined immunodeficiency (SCID) is the most severe form, characterized by the absence or dysfunction of T and B cells. Without early treatment, most infants with SCID do not survive their first year. In Ukraine, after a successful pilot project, newborn screening for SCID and other types of PID is now part of Advanced Neonatal Screening, using T-cell receptor excision circles (TREC) and kappa-deleting recombination excision circles (KREC) measurements. Since the pilot project used a different method than the current screening program, the purpose of this study was to compare these two methods, evaluating their benefits and downsides, aiming to optimize screening for early, effective treatment. Materials and Methods. In the pilot project method (Method 1), TREC and KREC quantification was performed using a custom real-time PCR assay with melting curve analysis. Method 1 included standards with known TREC and KREC copy numbers, no-template controls (NTCs), and positive controls to ensure reliable results. The method currently employed in the Advanced Neonatal Screening (Method 2) uses the Biocore® SMA/TKID PLUS Diagnostic Kit, a commercial kit, for TREC, KREC and SMN1 quantification via real-time PCR. Measurements for both methods are reported per one million cells. Results and Discussion. While there are differences in the general parameters of DNA extraction, PCR, and result analysis and interpretation, both Method 1 and Method 2 showed a significant difference in Cq values. Despite these differences, both methods demonstrated the capability of inentifying abnormal TREC/KREC values, enabling the detection of SCID and some PID cases. Conclusion. The pilot project demonstrated the effectiveness of TREC/KREC quantification for SCID screening and led to its implementation in Advanced Neonatal Screening in Ukraine. Over 121,000 newborns were tested, confirming six positive cases. Method 1 provides higher precision and versatility, while Method 2 is faster, simpler, and capable of automation but lacks precise quantification. Adding standards to Method 2 could enhance its utility for widespread SCID screening.
- 1 March 2025
- Published by Ivan Franko National University of Lviv in Studia Biologica
- Vol. 19 (1) , 35-46
Open AccessComparative analysis of two TREC/KREC quantification methods for newborn screening of primary immunodeficiency with T- and B-lymphopenia used in Ukraine
Background. Primary immunodeficiency (PID) compromise the immune system, leaving newborns highly vulnerable to infections. Severe combined immunodeficiency (SCID) is the most severe form, characterized by the absence or dysfunction of T and B cells. Without early treatment, most infants with SCID do not survive their first year. In Ukraine, after a successful pilot project, newborn screening for SCID and other types of PID is now part of Advanced Neonatal Screening, using T-cell receptor excision circles (TREC) and kappa-deleting recombination excision circles (KREC) measurements. Since the pilot project used a different method than the current screening program, the purpose of this study was to compare these two methods, evaluating their benefits and downsides, aiming to optimize screening for early, effective treatment. Materials and Methods. In the pilot project method (Method 1), TREC and KREC quantification was performed using a custom real-time PCR assay with melting curve analysis. Method 1 included standards with known TREC and KREC copy numbers, no-template controls (NTCs), and positive controls to ensure reliable results. The method currently employed in the Advanced Neonatal Screening (Method 2) uses the Biocore® SMA/TKID PLUS Diagnostic Kit, a commercial kit, for TREC, KREC and SMN1 quantification via real-time PCR. Measurements for both methods are reported per one million cells. Results and Discussion. While there are differences in the general parameters of DNA extraction, PCR, and result analysis and interpretation, both Method 1 and Method 2 showed a significant difference in Cq values. Despite these differences, both methods demonstrated the capability of inentifying abnormal TREC/KREC values, enabling the detection of SCID and some PID cases. Conclusion. The pilot project demonstrated the effectiveness of TREC/KREC quantification for SCID screening and led to its implementation in Advanced Neonatal Screening in Ukraine. Over 121,000 newborns were tested, confirming six positive cases. Method 1 provides higher precision and versatility, while Method 2 is faster, simpler, and capable of automation but lacks precise quantification. Adding standards to Method 2 could enhance its utility for widespread SCID screening.
- 29 October 2022
- Published by Group of Companies Med Expert, LLC in Modern pediatrics. Ukraine
- No. 6(126),p. 23-29
High frequency of the 472AA COMT (Val158) homozygous genotype of the catechol-O-methyltransferase (COMT) gene in children with irritable bowel syndrome
Following the biopsychosocial model of medicine, the pathophysiological basis of irritable bowel syndrome (IBS) is a combination of biological, psychoemotional, and psychosocial factors, the contribution of each of them to the development of this disorder remains unclear. Psychoemotinal factors, which are involved in the pathogenesis of IBS, are caused not only by the environment but also by the metabolism of catecholamines, particularly by the functional activity of catechol-O-methyltransferase (COMT). Purpose - to determine the role of Val158Met COMT polymorphism in development of IBS in children; to identify associations between genotype and clinical variant of the disorder and the nature of the provoking factor. Materials and methods. The material for the molecular genetic study were DNA samples obtained from nuclear cells of venous blood of 54 patients aged 6-12 years with diagnosed IBS. In 48 practically healthy children of the same age DNA samples were isolated from buccal epithelial cells. Molecular genetic study of single nucleotide polymorphism rs4680 of COMT gene was performed by polymerase chain reaction followed by analysis of restriction fragment length polymorphism. Microsoft Excel 2016 and GraphPad Prism 5 software were used for statistical analysis. Results. We have revealed significant differences in the distribution of Val158Met COMT genotypes in children with IBS in comparison with the control group. There was established that the 472GА COMT is more prevalent in healthy children and has a protective role in the development of IBS. In contrast, homozygous genotypes 472GG and 472AA, which are associated with changes in functional activity of enzyme COMT, may be considered as the risk factors for IBS (p≤0.0001). Conclusions. Genotype 472АА COMT was mostly detected in сhildren with stress-associated IBS, which is more related to dysnociception, disorders of cognition, and emotional disturbances. The higher prevalence of 472GA COMT heterozygotes among children with postinfectious IBS and IBS associated with antibiotic therapy indicates a less important role for the psychoemotional component and nociceptive disorders in the onset of this disorder (p=0.03). The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.
- 29 October 2022
- Published by Group of Companies Med Expert, LLC in Modern pediatrics. Ukraine
- No. 6(126),p. 23-29
High frequency of the 472AA COMT (Val158) homozygous genotype of the catechol-O-methyltransferase (COMT) gene in children with irritable bowel syndrome
Following the biopsychosocial model of medicine, the pathophysiological basis of irritable bowel syndrome (IBS) is a combination of biological, psychoemotional, and psychosocial factors, the contribution of each of them to the development of this disorder remains unclear. Psychoemotinal factors, which are involved in the pathogenesis of IBS, are caused not only by the environment but also by the metabolism of catecholamines, particularly by the functional activity of catechol-O-methyltransferase (COMT). Purpose - to determine the role of Val158Met COMT polymorphism in development of IBS in children; to identify associations between genotype and clinical variant of the disorder and the nature of the provoking factor. Materials and methods. The material for the molecular genetic study were DNA samples obtained from nuclear cells of venous blood of 54 patients aged 6-12 years with diagnosed IBS. In 48 practically healthy children of the same age DNA samples were isolated from buccal epithelial cells. Molecular genetic study of single nucleotide polymorphism rs4680 of COMT gene was performed by polymerase chain reaction followed by analysis of restriction fragment length polymorphism. Microsoft Excel 2016 and GraphPad Prism 5 software were used for statistical analysis. Results. We have revealed significant differences in the distribution of Val158Met COMT genotypes in children with IBS in comparison with the control group. There was established that the 472GА COMT is more prevalent in healthy children and has a protective role in the development of IBS. In contrast, homozygous genotypes 472GG and 472AA, which are associated with changes in functional activity of enzyme COMT, may be considered as the risk factors for IBS (p≤0.0001). Conclusions. Genotype 472АА COMT was mostly detected in сhildren with stress-associated IBS, which is more related to dysnociception, disorders of cognition, and emotional disturbances. The higher prevalence of 472GA COMT heterozygotes among children with postinfectious IBS and IBS associated with antibiotic therapy indicates a less important role for the psychoemotional component and nociceptive disorders in the onset of this disorder (p=0.03). The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.
- Open Access
- 31 March 2022
- Published by OU Scientific Route in EUREKA: Life Sciences
- No. 2,p. 36-44
Genetic testing of allelic variants of PIZ (GLU342Lys, RS28929474) and PIS (GLU264Val, RS17580) of SERPINA1 gene in children with bronchial asthma
According to world publications, mutations in the SERPINA1 gene may be a genetic risk factor for severe chronic obstructive pulmonary disease and, consequently, rapid progression of respiratory dysfunction. This disease leads to a decrease in the level of alpha-1-antitrypsin protein. It is inherited by autosomal recessive type, but there are registered cases of codominance. In the absence of treatment, diseases of the respiratory system become chronic and lead to disability in adulthood. Early diagnosis of AAT deficiency is important to prevent complications and reduce mortality among people with this pathology. Due to these factors, genetic testing of SERPINA1 gene mutations in children with chronic lung diseases is appropriate to detect and prevent severe complications, associated with AATD. The aim of this work is to improve the effectiveness of early diagnosis of AAT deficiency in children with bronchial asthma and recurrent obstructive bronchitis by identifying different genotypes and phenotypes of A1AT deficiency, studying their relationship with the clinical course of respiratory diseases in children
- 31 March 2022
- Published by OU Scientific Route in EUREKA: Life Sciences
- No. 2,p. 36-44
Open AccessGenetic testing of allelic variants of PIZ (GLU342Lys, RS28929474) and PIS (GLU264Val, RS17580) of SERPINA1 gene in children with bronchial asthma
According to world publications, mutations in the SERPINA1 gene may be a genetic risk factor for severe chronic obstructive pulmonary disease and, consequently, rapid progression of respiratory dysfunction. This disease leads to a decrease in the level of alpha-1-antitrypsin protein. It is inherited by autosomal recessive type, but there are registered cases of codominance. In the absence of treatment, diseases of the respiratory system become chronic and lead to disability in adulthood. Early diagnosis of AAT deficiency is important to prevent complications and reduce mortality among people with this pathology. Due to these factors, genetic testing of SERPINA1 gene mutations in children with chronic lung diseases is appropriate to detect and prevent severe complications, associated with AATD. The aim of this work is to improve the effectiveness of early diagnosis of AAT deficiency in children with bronchial asthma and recurrent obstructive bronchitis by identifying different genotypes and phenotypes of A1AT deficiency, studying their relationship with the clinical course of respiratory diseases in children
- Open Access
- 10 January 2021
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 9 (A) , 291-297
The Effects of Polymorphisms in One-carbon Metabolism Genes on Manifestation of Ichthyosis Vulgaris
BACKGROUND: Ichthyosis vulgaris is the most common type of Mendelian disorders of cornification, caused by loss-of-function mutations in the gene encoding epidermal protein filaggrin (FLG), namely R501X and 2282del4. FLG 2282del4 mutation in heterozygotes is incompletely penetrant. Polymorphisms in one-carbon metabolism genes could be associated with clinical manifestation of ichthyosis vulgaris. AIM: The purpose of the present study was to analyze the effects of MTHFR, MTR and MTRR polymorphisms in patients with ichthyosis vulgaris. METHODS: 31 patients with ichthyosis vulgaris, 7 their FLG heterozygous relatives without symptoms of disorder, and 150 healthy controls were enrolled in study. FLG null mutations —R501X (rs61816761) and 2282del4 (rs558269137) — and one-carbon metabolism gene polymorphisms — MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), MTR A2756G (rs1805087) and MTRR A66G (rs1801394) — were analyzed by a polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay. RESULTS: Among patients with ichthyosis, heterozygous for FLG 2282del4 mutation, the distributions of genotypes for folate metabolism genes were: MTHFR C677T CC:CT:TT —29.4%:70.6%:0.0%; MTHFR A1298C AA:AC:CC — 52.9%:47.1%:0.0%; MTR A2756G AA:AG:GG — 70.3%:23.5%:5.9%; MTRR A66G AA:AG:GG — 23.4%:52.9%:23.5%. The frequencies of MTR 2756AA and MTRR 66GG genotypes were 1.4–1.6 times higher in affected individuals heterozygous for 2282del4 than in patients with other FLG genotypes. In affected 2282del4 heterozygotes, the frequency of MTR 2756AA genotype was 1.6 times greater than in healthy controls (p<0.01). The strongest association was found between MTHFR 677CT/MTHFR 1298AA/MTR 2756AA/MTRR 66AG genotype and ichthyosis — OR=11.23 (95% CI 2.51−50.21, p=0.002). CONCLUSIONS: Various genotypes of one-carbon metabolism genes increase the risk of ichthyosis in heterozygotes for the FLG 2282del4 mutation (OR 2.799‑11.231). The most probable predisposing genotype is 677CT/1298AA/2756AA+AG/66AG.
- 10 January 2021
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 9 (A) , 291-297
Open AccessThe Effects of Polymorphisms in One-carbon Metabolism Genes on Manifestation of Ichthyosis Vulgaris
BACKGROUND: Ichthyosis vulgaris is the most common type of Mendelian disorders of cornification, caused by loss-of-function mutations in the gene encoding epidermal protein filaggrin (FLG), namely R501X and 2282del4. FLG 2282del4 mutation in heterozygotes is incompletely penetrant. Polymorphisms in one-carbon metabolism genes could be associated with clinical manifestation of ichthyosis vulgaris. AIM: The purpose of the present study was to analyze the effects of MTHFR, MTR and MTRR polymorphisms in patients with ichthyosis vulgaris. METHODS: 31 patients with ichthyosis vulgaris, 7 their FLG heterozygous relatives without symptoms of disorder, and 150 healthy controls were enrolled in study. FLG null mutations —R501X (rs61816761) and 2282del4 (rs558269137) — and one-carbon metabolism gene polymorphisms — MTHFR C677T (rs1801133), MTHFR A1298C (rs1801131), MTR A2756G (rs1805087) and MTRR A66G (rs1801394) — were analyzed by a polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay. RESULTS: Among patients with ichthyosis, heterozygous for FLG 2282del4 mutation, the distributions of genotypes for folate metabolism genes were: MTHFR C677T CC:CT:TT —29.4%:70.6%:0.0%; MTHFR A1298C AA:AC:CC — 52.9%:47.1%:0.0%; MTR A2756G AA:AG:GG — 70.3%:23.5%:5.9%; MTRR A66G AA:AG:GG — 23.4%:52.9%:23.5%. The frequencies of MTR 2756AA and MTRR 66GG genotypes were 1.4–1.6 times higher in affected individuals heterozygous for 2282del4 than in patients with other FLG genotypes. In affected 2282del4 heterozygotes, the frequency of MTR 2756AA genotype was 1.6 times greater than in healthy controls (p<0.01). The strongest association was found between MTHFR 677CT/MTHFR 1298AA/MTR 2756AA/MTRR 66AG genotype and ichthyosis — OR=11.23 (95% CI 2.51−50.21, p=0.002). CONCLUSIONS: Various genotypes of one-carbon metabolism genes increase the risk of ichthyosis in heterozygotes for the FLG 2282del4 mutation (OR 2.799‑11.231). The most probable predisposing genotype is 677CT/1298AA/2756AA+AG/66AG.